September 8, 2024

FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

 FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

FDA Reviews MDMA Therapy for PTSD, Citing Health Risks and Study Flaws

The agency’s staff analysis suggests that approval of the illegal drug known as Ecstasy for treatment of PTSD is far from certain, with advisers meeting next week to consider the proposed therapy.

Andrew Jacobs and Christina Jewett